Skip to main content
Erschienen in: Nutrition Journal 1/2003

Open Access 01.12.2003 | Research

Validation of the MEDFICTS dietary questionnaire: A clinical tool to assess adherence to American Heart Association dietary fat intake guidelines

verfasst von: Allen J Taylor, Henry Wong, Karen Wish, Jon Carrow, Debulon Bell, Jody Bindeman, Tammy Watkins, Trudy Lehmann, Saroj Bhattarai, Patrick G O'Malley

Erschienen in: Nutrition Journal | Ausgabe 1/2003

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Dietary assessment tools are often too long, difficult to quantify, expensive to process, and largely used for research purposes. A rapid and accurate assessment of dietary fat intake is critically important in clinical decision-making regarding dietary advice for coronary risk reduction. We assessed the validity of the MEDFICTS (MF) questionnaire, a brief instrument developed to assess fat intake according to the American Heart Association (AHA) dietary "steps".

Methods

We surveyed 164 active-duty US Army personnel without known coronary artery disease at their intake interview for a primary prevention cardiac intervention trial using the Block food frequency (FFQ) and MF questionnaires. Both surveys were completed on the same intake visit and independently scored. Correlations between each tools' assessment of fat intake, the agreement in AHA step categorization of dietary quality with each tool, and the test characteristics of the MF using the FFQ as the gold standard were assessed.

Results

Subjects consumed a mean of 36.0 ± 13.0% of their total calories as fat, which included saturated fat consumption of 13.0 ± 0.4%. The majority of subjects (125/164; 76.2%) had a high fat (worse than AHA Step 1) diet. There were significant correlations between the MF and the FFQ for the intake of total fat (r = 0.52, P < 0.0001) and saturated fat (r = 0.52, P < 0.0001). Despite these modest correlations, the currently recommended MF cutpoints correctly identified only 29 of 125 (23.3%) high fat (worse than AHA Step 1) diets. Overall agreement for the AHA diet step between the FFQ and MF (using the previously proposed MF score cutoffs of 0–39 [AHA Step 2], 40–70 [Step 1], and >70 [high fat diet]) was negligible (kappa statistic = 0.036). The MF was accurate at the extremes of fat intake, but could not reliably identify the 3 AHA dietary classifications. Alternative MF cutpoints of <30 (Step 2), 30–50 (Step 1), and >50 (high fat diet) were highly sensitive (96%), but had low specificity (46%) for a high fat diet. ROC curve analysis identified that a MF score cutoff of 38 provided optimal sensitivity 75% and specificity 72%, and had modest agreement (kappa = 0.39, P < 0.001) with the FFQ for the identification of subjects with a high fat diet.

Conclusions

The MEDFICTS questionnaire is most suitable as a tool to identify high fat diets, rather than discriminate AHA Step 1 and Step 2 diets. Currently recommended MEDFICTS cutpoints are too high, leading to overestimation of dietary quality. A cutpoint of 38 appears to be providing optimal identification of patients who do not meet AHA dietary guidelines for fat intake.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1475-2891-2-4) contains supplementary material, which is available to authorized users.

Background

Dietary fat intake is a risk factor for coronary heart disease and the modification of dietary habits is important for the prevention of cardiovascular disease. The assessment of dietary fat intake is a critically important first step in clinical decision-making regarding dietary and pharmacotherapeutic advice on coronary risk reduction. Thus, a rapid and accurate tool to assess dietary fat intake would be a clinically useful screening tool for physicians to counsel patients about diet and coronary risk reduction.
Commonly used dietary assessment tools include dietary history, 24-hour recall, seven-day recall, seven-day record, and food frequency questionnaire. [17] Impediments to more widespread clinical use of these tools include their length, and the difficulty and expense of their analysis. Furthermore, nutrition researchers tend to focus on a method's ability to yield precise and accurate measurement of a nutrient rather than to evaluate whether a tool can simply and quickly identify an individual's distribution or pattern of food intake. We compared the accuracy of the MEDFICTS (MF) questionnaire,[8] a brief instrument developed to assess fat intake according to the American Heart Association (AHA) dietary "steps,"[9, 10] to the standardized Block Food Frequency Questionnaire[11, 12] (FFQ) in a sample of active duty US Army personnel without known coronary artery disease.

Methods

Subjects

This study contains data from 164 active-duty U.S. Army personnel who completed both the MF and Block FFQ. Subjects completed the surveys during the same intake interview for a primary prevention intervention trial – the Prospective Army Coronary Calcium (PACC) Study. The study was approved by the Department of Clinical Investigation of the Walter Reed Army Medical Center.
The methods of the PACC Study have been previously described.[13] Briefly, since October 1998, active-duty Army personnel from 39 through 45 of age who were stationed in the National Capital Area of the Walter Reed Health Care System were recruited at the time of a periodic, Army-mandated physical examination. Persons who had a history of coronary heart disease or who reported a history of angina pectoris on the Rose questionnaire were ineligible. Between October 26, 1998 and November 4, 1999, 705 eligible participants were screened and 630 provided written informed consent to undergo electron beam computed tomography (EBCT) in addition to the required physical examination procedures. A subset of these subjects also volunteered to participate in a randomized, controlled trial to assess the impact of the knowledge of EBCT results and nurse-based case management on risk factor modification. The 164 subjects included in this dietary assessment study are a consecutive sample of subjects who both consented to participate in the randomized controlled trial and who also completed the MF and Block FFQ questionnaires. Demographic characteristics of the study participants are shown in Table 1.
Table 1
Demographic Characteristics and Select Cardiac Risk Factors of the PACC Participants (N = 164)
Variable
Value*
Demographic Characteristics:
 
   Male gender (%)
79.9
   Age (yr)
42 ± 2
   Caucasian (%)
65.9
   College educated (%)
78.4
Cardiac Risk Factors:
 
   Total cholesterol (mg/dl)
203 ± 34
   LDL (mg/dl)
130 ± 33
   HDL (mg/dl)
52 ± 14
   Triglycerides (mg/dl)
117 ± 64
   BMI
27 ± 4
   Waist girth (cm)
92 ± 10
*Plus-minus values are means and standard deviations.

Dietary Assessment Tools

Each participant filled out a series of questionnaires that included the 2 dietary assessment tools: the validated and reduced version of the Block FFQ and the full version of the MF. The reduced version of Block FFQ is a validated food survey that contains 60 food items and is intended to capture all nutrients in the diet including dietary fat intake. The survey requires approximately 15 minutes to self-administer, however, the survey requires a relatively detailed analysis, thus the results are not immediately available for patient counseling. This study focuses only on those variables from the Block FFQ that are relevant to dietary fat intake within the dietary guidelines of the American Heart Association (AHA). This includes total calories, percentage of calories from fat and saturated fat, and cholesterol intake.
The MF questionnaire was specifically designed to evaluate patient adherence to the National Cholesterol Education Program (NCEP) Step 1 and Step 2 diets adopted by the American Heart Association (AHA). The main objective of these dietary steps is incrementally reduce coronary heart disease risk through diet-induced reduction in LDL cholesterol. Both the AHA Step 1 and 2 diets focus on reducing total fat to 30% or less of daily energy, and progressively reducing saturated fat and cholesterol intake (Step 1: 7–10% of energy from saturated fat and <300 mg cholesterol; Step 2: <7% of energy from saturated fat and <200 mg cholesterol). The AHA Step 1 diet is recommended for all healthy persons for the prevention of coronary heart disease, and is recommended to precede pharmacotherapy of LDL cholesterol. The Step 2 diet is recommended to further reduce LDL cholesterol for patients that have already achieved their Step 1 dietary goals. Additionally, the Step 2 diet is the initially recommended diet for patients with either a high-risk cholesterol level (>240 mg/dL) or with known coronary heart disease.
The MEDFICTS questionnaire is a brief instrument consisting of 8 food categories: Meats, Eggs, Dairy, Fried foods, fat In baked goods, Convenience foods, fats added at the Table, and Snacks. The first column of the questionnaire addresses each of these food categories. Within each category, food items are assigned to either group 1 (desirable) or group 2 (undesirable) based upon total fat content. Numeric values are assigned to each food group, with weightings based upon weekly consumption and serving size. The questionnaire is scored using totaling the quality-adjusted intake quantity yielding a possible range of scores from 0 to 216 points. Lower MF scores indicate diets containing less dietary fat. Prior validation literature indicated that a score of <40 points is consistent with a Step 2 diet, a score between 40 to 69 is consistent with a Step 1 diet, and a score of >70 is considered as high fat diet. The MF can be self-administered in 3 to 5 minutes, and scored by the healthcare provider in approximately 2 minutes. Thus, the MF is an efficient tool enabling health care providers to quickly assess the adherence of patients to the fat components of a Step 1 or 2 diet, and identify patients consuming a diet higher in total fat, saturated fat, and cholesterol.

Statistical Analysis

The two dietary questionnaires were independently scored. The reduced version Block FFQ was coded and analyzed by the same investigator to provide consistency in scoring. The validation of MF scores with Block FFQ dietary variables (percent of fat, percentage of saturated fat, and cholesterol level) was evaluated by Spearman's rho, because both dietary scores were not normally distributed. The level of inter-test agreement between the two dietary instruments was assessed using the kappa statistic. Receiver operating characteristic (ROC) Curve analysis was applied to measure the sensitivity and specificity of the alternative MF cutpoints. All analyses were performed using SPSS for Windows (v 10.05, Chicago, IL). Data are presented as mean ± SD. A two-tailed P value of ≤ 0.05 was considered to indicate statistical significance.

Results

Mean daily intake values included total fat (% calories) of 35.5 ± 13.0%, saturated fat 13.0 ± 0.4%, and cholesterol 267 ± 283 mg/dL. These data, obtained with the Block FFQ, indicated that 76.2% of the participants had a high fat (worse than the AHA Step 1) diet. In contrast, the MF questionnaire identified only 17.7% of the group as having a high fat diet (Table 2). The other subjects (82.3%) were indicated as having a low fat diet, and were approximately equally divided between AHA Step 1 and 2 diets.
Table 2
Dietary data for the study group
Dietary Data
Male (N = 131)
Female (N = 33)
Total (N = 164)
MEDFICTS Data:
   
   Diet Group Distribution (%)*
   
High fat diet
19.8
9.1
17.7
Step 1 diet
44.3
39.4
43.3
Step 2 diet
35.9
51.5
39.0
   Total MEDFICTS Score
49 ± 27**
41 ± 27
48 ± 27
Block Dietary Data:
   
   Total Calories
1576 ± 674
1321 ± 530
1525 ± 654
   % fat
35.8 ± 14.0
34.4 ± 1.0
35.5 ± 13.0
   % saturated fat
12.7 ± 0.4
12.2 ± 0.4
12.6 ± 0.4
   Cholesterol (mg/dl)
283 ± 311
201 ± 98
267 ± 283
* MEDFICTS Diet Groups: High fat diet group: MEDFICTS score >70 Step 1 diet group: MEDFICTS score: 40–70 <30% fat, <10% saturated fat, <300 mg/dl cholesterol Step 2 diet group: MEDFICTS score <40 <30% fat, <7% saturated fat, <200 mg/dl cholesterol Data shown are means ± standard deviations.
There were significant correlations between the MF and Block FFQ for the percentage intake of fat (r = 0.52, P < 0.0001), saturated fat (r = 0.52, P < 0.0001), and cholesterol (r = 0.55, P < 0.0001). Subjects within the different MF diet categories did significantly differ with respect to fat intake (Table 3). Despite these modest correlations, the MF (based on the currently-recommended MF score cutoffs of 0–39 for Step 2, 40–70 for Step 1, and >70 for high fat diets) correctly identified only 29 of 125 (23.3%) high fat (worse than AHA Step 1) diets, and 19.2% of Step 1 diets (Table 4). The overall agreement for the AHA diet steps between the Block FFQ and MF was negligible (kappa statistics = 0.036). The MF was accurate at the extremes of fat intake, but could not reliably separate patient groups into 3 AHA dietary classifications.
Table 3
Comparisons of daily caloric, fat and cholesterol intake within MEDFICTS Diet Groups
Block Dietary
High Fat
Step 1
Step 2
ANOVA
Variable
Diet
Diet
Diet
F
Sig.
Total calories
1980
1540
1302
12.3
.0001
% fat
40.9
38
30.3
10.1
.0001
% saturated fat
15.7
13.1
10.6
22.1
.0001
Cholesterol
351
309
181
5.3
.006
Table 4
MEDFICTS Diet Groups and AHA Diet Steps Crosstabulation
MEDFICTS Diet Groups
AHA Diet Steps
 
High Fat
Step 1
Step 2
Total
High Fat Diet
29 (100.0%)* (23.2%)**
  
29 (100.0%) (17.7%)
Step 1 Diet
62 (87.3%) (49.6%)
5 (7.0%) (19.2%)
4 (5.6%) (30.8%)
71 (100.0%) (43.3%)
Step 2 Diet
34 (53.1%) (27.2%)
21 (32.8%) (80.8%)
9 (14.1%) (69.2%)
64 (100.0%) (39.0%)
Total
125 (76.2%) (100.0%)
26 (15.9%) (100.0%)
13 (7.9%) (100.0%)
164 (100.0%) (100.0%)
* % within MEDFICTS diet groups. ** % within AHA diet steps.
Exploratory analysis showed that alternative MF cutpoints of <30 (Step 2), 30–50 (Step 1), and >50 (high fat diet) were highly sensitive (96%), but had low specificity (46%) for a high fat diet. Receiver operating characteristic (ROC) curve analysis showed that a single MF score cutoff of 38 yielded optimal sensitivity of 75% and specificity of 72% (Figure 1), and had modest agreement (kappa statistics = 0.39, P < 0.001) with the Block FFQ for the identification of patients with a high fat diet (Figure).

Discussion

The effective identification of patients requiring dietary intervention for the reduction of fat intake requires an accurate, efficient, clinically applicable dietary assessment tool. In this study, we compared the accuracy of the MEDFICTS dietary survey to the Block FFQ for the identification of compliance with the AHA dietary guidelines for fat intake. These data indicate that the MF questionnaire has moderate accuracy for the semi-quantitation of dietary fat and saturated fat intake. However, the currently-recommended MF cutpoints resulted in marked over-estimation of dietary quality, including an inability to accurately detect high fat diets. Furthermore, this tool does not appear to have adequate test characteristics to accurately discriminate Step 1 and Step 2 diets. This is likely due to the small differences in fat intake between these 2 diets, and the relatively crude nature of the MF survey. However, our data suggest that a revised cutpoint of 38 for the MF questionnaire resulted in modest accuracy for the detection of a high fat diet.
Beyond ease of administration, an additional advantage of the MF survey may be its utility as a tool for dietary education and lifestyle modification. The content and design of the MF is clear and simple, but comprehensive enough to categorically provide dietary fat intake guidance for a wide variety of food goods. The survey provides rapid depiction of the greatest contributors to dietary fat intake within a given patient's diet, and suggests strategies (alternative food choices, or reduced portion size) for the reduction of dietary fat. However, whether the MF would serve as a useful tool to guide dietary modification will require further study.

Conclusions

The MF questionnaire is an efficient tool that can be used by health professionals to quickly assess the dietary fat intake. It provides immediate identification of patients consuming a diet higher in total fat, saturated fat, and cholesterol than currently recommended by the American Heart Association. However, the current recommended cutpoints of the MEDFICTS questionnaire are unable to discriminate the AHA Step 1 and Step 2 diets. Current MEDFICTS cutpoints are too high, leading to overestimation of dietary quality. A cutpoint of 38 appears to be providing optimal identification of patients who do not meet AHA dietary guidelines for fat intake.
Allen J. Taylor- Project design, data analysis, manuscript preparation Henry Wong- Project design, data analysis, manuscript preparation Karen Wish- Primary data analysis, manuscript preparation Jon Carrow- Data collection, data analysis, manuscript preparation Debulon Bell- Data collection, data analysis, manuscript preparation Jody Bindeman- Data collection, data analysis, manuscript preparation Tammy Watkins- Data collection, data analysis, manuscript preparation Trudy Lehmann- Data collection, data analysis, manuscript preparation Saroj Bhattarai- Data management, data analysis, manuscript preparation Patrick G. O'Malley- Project design, data analysis, manuscript preparation
Anhänge

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.
Literatur
1.
Zurück zum Zitat Beaton GH, Milner J, Corey P, McGuire V, Cousins M, Stewart E, et al: Sources of variance in 24-hour dietary recall data: implications for nutrition study design and interpretation. Am J Clin Nutr. 1979, 32: 2546-2549.PubMed Beaton GH, Milner J, Corey P, McGuire V, Cousins M, Stewart E, et al: Sources of variance in 24-hour dietary recall data: implications for nutrition study design and interpretation. Am J Clin Nutr. 1979, 32: 2546-2549.PubMed
2.
Zurück zum Zitat Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L: A data-based approach to diet questionnaire design and testing. Am J Epidemiol. 1986, 124: 453-469.PubMed Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L: A data-based approach to diet questionnaire design and testing. Am J Epidemiol. 1986, 124: 453-469.PubMed
3.
Zurück zum Zitat Briefel RR, Flegal KM, Winn DM, Loria CM, Johnson CL, Sempos CT: Assessing the nation's diet: limitations of the food frequency questionnaire. J Am Diet Assoc. 1992, 92: 959-962.PubMed Briefel RR, Flegal KM, Winn DM, Loria CM, Johnson CL, Sempos CT: Assessing the nation's diet: limitations of the food frequency questionnaire. J Am Diet Assoc. 1992, 92: 959-962.PubMed
4.
Zurück zum Zitat Hankin JH, Nomura AM, Lee J, Hirohata T, Kolonel LN: Reproducibility of a diet history questionnaire in a case-control study of breast cancer. Am J Clin Nutr. 1983, 37: 981-985.PubMed Hankin JH, Nomura AM, Lee J, Hirohata T, Kolonel LN: Reproducibility of a diet history questionnaire in a case-control study of breast cancer. Am J Clin Nutr. 1983, 37: 981-985.PubMed
5.
Zurück zum Zitat Neuhouser ML, Kristal AR, McLerran D, Patterson RE, Atkinson J: Validity of short food frequency questionnaires used in cancer chemoprevention trials: results from the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev. 1999, 8: 721-725.PubMed Neuhouser ML, Kristal AR, McLerran D, Patterson RE, Atkinson J: Validity of short food frequency questionnaires used in cancer chemoprevention trials: results from the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev. 1999, 8: 721-725.PubMed
6.
Zurück zum Zitat Olendzki B, Hurley TG, Hebert JR, Ellis S, Merriam PA, Luippold R, et al: Comparing food intake using the Dietary Risk Assessment with multiple 24-hour dietary recalls and the 7-Day Dietary Recall. J Am Diet Assoc. 1999, 99: 1433-1439. 10.1016/S0002-8223(99)00346-6.CrossRefPubMed Olendzki B, Hurley TG, Hebert JR, Ellis S, Merriam PA, Luippold R, et al: Comparing food intake using the Dietary Risk Assessment with multiple 24-hour dietary recalls and the 7-Day Dietary Recall. J Am Diet Assoc. 1999, 99: 1433-1439. 10.1016/S0002-8223(99)00346-6.CrossRefPubMed
7.
Zurück zum Zitat Gersovitz M, Madden JP, Smiciklas-Wright H: Validity of the 24-hr. dietary recall and seven-day record for group comparisons. J Am Diet Assoc. 1978, 73: 48-55.PubMed Gersovitz M, Madden JP, Smiciklas-Wright H: Validity of the 24-hr. dietary recall and seven-day record for group comparisons. J Am Diet Assoc. 1978, 73: 48-55.PubMed
8.
Zurück zum Zitat Kris-Etherton P, Eissenstat B, Jaax S, Srinath U, Scott L, Rader J, et al: Validation for MEDFICTS, a dietary assessment instrument for evaluating adherence to total and saturated fat recommendations of the National Cholesterol Education Program Step 1 and Step 2 diets. J Am Diet Assoc. 2001, 101: 81-86. 10.1016/S0002-8223(01)00020-7.CrossRefPubMed Kris-Etherton P, Eissenstat B, Jaax S, Srinath U, Scott L, Rader J, et al: Validation for MEDFICTS, a dietary assessment instrument for evaluating adherence to total and saturated fat recommendations of the National Cholesterol Education Program Step 1 and Step 2 diets. J Am Diet Assoc. 2001, 101: 81-86. 10.1016/S0002-8223(01)00020-7.CrossRefPubMed
9.
Zurück zum Zitat Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, et al: AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation. 2000, 102: 2284-2299.CrossRefPubMed Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, et al: AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation. 2000, 102: 2284-2299.CrossRefPubMed
10.
Zurück zum Zitat National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 1994, 89: 1333-1445. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 1994, 89: 1333-1445.
11.
Zurück zum Zitat Block G, Hartman AM, Naughton D: A reduced dietary questionnaire: development and validation. Epidemiology. 1990, 1: 58-64.CrossRefPubMed Block G, Hartman AM, Naughton D: A reduced dietary questionnaire: development and validation. Epidemiology. 1990, 1: 58-64.CrossRefPubMed
12.
Zurück zum Zitat Potischman N, Carroll RJ, Iturria SJ, Mittl B, Curtin J, Thompson FE, et al: Comparison of the 60-and 100-item NCI-block questionnaires with validation data. Nutr Cancer. 1999, 34: 70-75. 10.1207/S15327914NC340110.CrossRefPubMed Potischman N, Carroll RJ, Iturria SJ, Mittl B, Curtin J, Thompson FE, et al: Comparison of the 60-and 100-item NCI-block questionnaires with validation data. Nutr Cancer. 1999, 34: 70-75. 10.1207/S15327914NC340110.CrossRefPubMed
13.
Zurück zum Zitat O'Malley PG, Taylor AJ, Gibbons RV, Feuerstein IM, Jones DL, Vernalis M, et al: Rationale and design of the Prospective Army Coronary Calcium (PACC) Study: utility of electron beam computed tomography as a screening test for coronary artery disease and as an intervention for risk factor modification among young, asymptomatic, active-duty United States Army Personnel. Am Heart J. 1999, 137: 932-941.CrossRefPubMed O'Malley PG, Taylor AJ, Gibbons RV, Feuerstein IM, Jones DL, Vernalis M, et al: Rationale and design of the Prospective Army Coronary Calcium (PACC) Study: utility of electron beam computed tomography as a screening test for coronary artery disease and as an intervention for risk factor modification among young, asymptomatic, active-duty United States Army Personnel. Am Heart J. 1999, 137: 932-941.CrossRefPubMed
Metadaten
Titel
Validation of the MEDFICTS dietary questionnaire: A clinical tool to assess adherence to American Heart Association dietary fat intake guidelines
verfasst von
Allen J Taylor
Henry Wong
Karen Wish
Jon Carrow
Debulon Bell
Jody Bindeman
Tammy Watkins
Trudy Lehmann
Saroj Bhattarai
Patrick G O'Malley
Publikationsdatum
01.12.2003
Verlag
BioMed Central
Erschienen in
Nutrition Journal / Ausgabe 1/2003
Elektronische ISSN: 1475-2891
DOI
https://doi.org/10.1186/1475-2891-2-4

Weitere Artikel der Ausgabe 1/2003

Nutrition Journal 1/2003 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.